DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
RP-6530
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RP-6530
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COCAETHYLENE
1
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders
Unknown
COCAETHYLENE
×
Maximum Phase:
1
First Approval:
None
UNII:
FJO3071W5Y
Molecule Type:
Small molecule
Molecular Formula:
C18H23NO4
Molecular Weight:
317.39
AlogP:
2.26
PSA:
55.84
HBD:
0.0
HBA:
#RotB:
4.0
Source:
OLOCROLIMUS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
FK506-binding protein 1A inhibitor
OLOCROLIMUS
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABTL-0812
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ABTL-0812
×
Maximum Phase:
1
First Approval:
None
UNII:
0DE74TJ7EZ
Molecule Type:
Small molecule
Molecular Formula:
C18H32O3
Molecular Weight:
296.45
AlogP:
4.86
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
14.0
Source:
NUMIDARGISTAT
1
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms; Multiple Myeloma; Neoplasms
Unknown
NUMIDARGISTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
IFD73D535A
Molecule Type:
Small molecule
Molecular Formula:
C11H22BN3O5
Molecular Weight:
287.12
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CHROMIUM PICOLINATE
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Feeding and Eating Disorders
Unknown
CHROMIUM PICOLINATE
×
Maximum Phase:
1
First Approval:
None
UNII:
S71T8B8Z6P
Molecule Type:
Small molecule
Molecular Formula:
C18H12CrN3O6
Molecular Weight:
417.25
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
GET-73
1
Small molecule
Investigational
Unknown
Unknown
Alcoholism
Unknown
GET-73
×
Maximum Phase:
1
First Approval:
None
UNII:
U5CLZ223FH
Molecule Type:
Small molecule
Molecular Formula:
C13H16F3NO2
Molecular Weight:
275.27
AlogP:
2.75
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
6.0
Source:
11C-MK-3168
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
11C-MK-3168
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-8165
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD-8165
×
Maximum Phase:
1
First Approval:
None
UNII:
7WO8I5IY24
Molecule Type:
Small molecule
Molecular Formula:
C23H21ClFN7O4
Molecular Weight:
513.92
AlogP:
2.35
PSA:
131.67
HBD:
1.0
HBA:
#RotB:
8.0
Source:
TTP-607
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
TTP-607
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GMI-1271
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GMI-1271
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZIDEBACTAM
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
ZIDEBACTAM
×
Maximum Phase:
1
First Approval:
None
UNII:
YPM97423DB
Molecule Type:
Small molecule
Molecular Formula:
C13H21N5O7S
Molecular Weight:
391.41
AlogP:
-1.86
PSA:
157.38
HBD:
4.0
HBA:
#RotB:
4.0
Source:
PELCITOCLAX
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin; Neuroendocrine Tumors; Primary Myelofibrosis; Small Cell Lung Carcinoma
Unknown
PELCITOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
317UBD60ML
Molecule Type:
Small molecule
Molecular Formula:
C57H66ClF4N6O11PS4
Molecular Weight:
1281.87
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RO-3201195
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
RO-3201195
×
Maximum Phase:
1
First Approval:
None
UNII:
TE3ESF890C
Molecule Type:
Small molecule
Molecular Formula:
C19H18FN3O4
Molecular Weight:
371.37
AlogP:
1.56
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
7.0
Source:
PF-06815345
1
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia
Unknown
PF-06815345
×
Maximum Phase:
1
First Approval:
None
UNII:
4H9X9HO87K
Molecule Type:
Small molecule
Molecular Formula:
C27H29ClFN9O4
Molecular Weight:
598.04
AlogP:
4.02
PSA:
142.18
HBD:
1.0
HBA:
#RotB:
8.0
Source:
FRUCTOSE
1
Small molecule
Investigational
Unknown
Unknown
Hypoglycemia; Melanoma; Non-alcoholic Fatty Liver Disease; Obesity
Unknown
FRUCTOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
6YSS42VSEV
Molecule Type:
Small molecule
Molecular Formula:
C6H12O6
Molecular Weight:
180.16
AlogP:
-3.22
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
2.0
Source:
HSD-016
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HSD-016
×
Maximum Phase:
1
First Approval:
None
UNII:
C4I13768E1
Molecule Type:
Small molecule
Molecular Formula:
C21H21F7N2O3S
Molecular Weight:
514.46
AlogP:
4.51
PSA:
60.85
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MIP-1095 I-123
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIP-1095 I-123
×
Maximum Phase:
1
First Approval:
None
UNII:
HD4940602J
Molecule Type:
Small molecule
Molecular Formula:
C19H25IN4O8
Molecular Weight:
560.33
AlogP:
1.65
PSA:
194.16
HBD:
7.0
HBA:
#RotB:
13.0
Source:
S-3304
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Neoplasms
Unknown
S-3304
×
Maximum Phase:
1
First Approval:
None
UNII:
BK459F050X
Molecule Type:
Small molecule
Molecular Formula:
C24H20N2O4S2
Molecular Weight:
464.57
AlogP:
3.91
PSA:
99.26
HBD:
3.0
HBA:
#RotB:
6.0
Source:
2MD
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
2MD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETC-159
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
ETC-159
×
Maximum Phase:
1
First Approval:
None
UNII:
5L854240DQ
Molecule Type:
Small molecule
Molecular Formula:
C19H17N7O3
Molecular Weight:
391.39
AlogP:
0.53
PSA:
116.7
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BMS-830216
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
BMS-830216
×
Maximum Phase:
1
First Approval:
None
UNII:
ISL723GVQ8
Molecule Type:
Small molecule
Molecular Formula:
C24H22ClN2O7PS
Molecular Weight:
548.94
AlogP:
5.04
PSA:
120.11
HBD:
2.0
HBA:
#RotB:
9.0
Source:
MUBRITINIB
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Kidney Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms
Receptor protein-tyrosine kinase erbB-2 inhibitor
MUBRITINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
V734AZP9BR
Molecule Type:
Small molecule
Molecular Formula:
C25H23F3N4O2
Molecular Weight:
468.48
AlogP:
6.06
PSA:
65.97
HBD:
0.0
HBA:
#RotB:
10.0
Source:
PLX8394
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PLX8394
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
YTTRIUM Y-90
1
Small molecule
Investigational
Unknown
Unknown
Neoplasm Metastasis; Neoplasms; Bile Duct Neoplasms; Cholangiocarcinoma
Unknown
YTTRIUM Y-90
×
Maximum Phase:
1
First Approval:
None
UNII:
1K8M7UR6O1
Molecule Type:
Small molecule
Molecular Formula:
Y
Molecular Weight:
89.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CP-609754
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Neoplasms
Unknown
CP-609754
×
Maximum Phase:
1
First Approval:
None
UNII:
L0S47W9GPY
Molecule Type:
Small molecule
Molecular Formula:
C29H22ClN3O2
Molecular Weight:
479.97
AlogP:
4.86
PSA:
60.05
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TRODUSQUEMINE
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
TRODUSQUEMINE
×
Maximum Phase:
1
First Approval:
None
UNII:
KKC12PIF16
Molecule Type:
Small molecule
Molecular Formula:
C37H72N4O5S
Molecular Weight:
685.07
AlogP:
5.53
PSA:
145.94
HBD:
6.0
HBA:
#RotB:
20.0
Source:
ORDOPIDINE
1
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Dopamine D2 receptor modulator
ORDOPIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
0P43SIA7J6
Molecule Type:
Small molecule
Molecular Formula:
C14H20FNO2S
Molecular Weight:
285.38
AlogP:
2.43
PSA:
37.38
HBD:
0.0
HBA:
#RotB:
3.0
Source:
CORDYCEPIN
1
Small molecule
Investigational
Unknown
Unknown
Leukemia
Unknown
CORDYCEPIN
×
Maximum Phase:
1
First Approval:
None
UNII:
GZ8VF4M2J8
Molecule Type:
Small molecule
Molecular Formula:
C10H13N5O3
Molecular Weight:
251.25
AlogP:
-0.95
PSA:
119.31
HBD:
3.0
HBA:
#RotB:
2.0
Source:
CAFUSERTIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Neoplasms
Serine/threonine-protein kinase PLK1 inhibitor
CAFUSERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DCC-2036
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DCC-2036
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK2981278
1
Small molecule
Investigational
Unknown
Unknown
Psoriasis
Unknown
GSK2981278
×
Maximum Phase:
1
First Approval:
None
UNII:
L49V5G013I
Molecule Type:
Small molecule
Molecular Formula:
C25H35NO5S
Molecular Weight:
461.62
AlogP:
4.4
PSA:
76.07
HBD:
1.0
HBA:
#RotB:
10.0
Source:
HENATINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Vascular endothelial growth factor receptor 2 inhibitor
HENATINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
TE20GB753F
Molecule Type:
Small molecule
Molecular Formula:
C25H29FN4O4
Molecular Weight:
468.53
AlogP:
2.04
PSA:
97.9
HBD:
3.0
HBA:
#RotB:
5.0
Source:
SIRPIGLENASTAT
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Neoplasms
Unknown
SIRPIGLENASTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
9GGE6A0ZMK
Molecule Type:
Small molecule
Molecular Formula:
C22H27N5O5
Molecular Weight:
441.49
AlogP:
1.3
PSA:
153.76
HBD:
3.0
HBA:
#RotB:
11.0
Source:
LB-102
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
LB-102
×
Maximum Phase:
1
First Approval:
None
UNII:
N81WKW91XF
Molecule Type:
Small molecule
Molecular Formula:
C18H29N3O4S
Molecular Weight:
383.51
AlogP:
1.74
PSA:
87.74
HBD:
2.0
HBA:
#RotB:
8.0
Source:
1
2
…
66
67
68
69
70
71
72
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA